Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Neuroendocrine Tumor
100%
Radioligand
100%
Clinical Translation
100%
Octreotate
100%
18F-fluoroethyl-L-tyrosine (18F-FET)
80%
Effective Dose
40%
Metastasis
40%
Spleen
40%
Tumor
20%
Liver
20%
Salivary Gland
20%
Radioactivity
20%
Adverse Events
20%
Gallbladder
20%
Preclinical Imaging
20%
Safety Data
20%
Stomach
20%
Residence Time
20%
Region of Interest
20%
Physiologic
20%
Dosimetry
20%
Bladder
20%
Pituitary
20%
Absorbed Dose
20%
Biodistribution
20%
Multiple Endocrine Neoplasia Type 1 (MEN1)
20%
Tumor Activity
20%
Venous Blood
20%
Dosimetric
20%
Triazole
20%
Background Contrast
20%
Imaging Standards
20%
Low Background
20%
Metabolite Quantification
20%
Multi-bed
20%
OLINDA
20%
Clinical Detection
20%
Image Quantification
20%
Image Detection
20%
Background Distribution
20%
Tyr3-octreotate
20%
Positron Emission Tomography/computed Tomography (PET/CT)
20%
Liver-kidney
20%
Whole-body PET
20%
Contrast Image
20%
First-in-human
20%
Medicine and Dentistry
Fluorine-18
100%
Neuroendocrine Tumor
100%
Radioligand
100%
Metastatic Carcinoma
33%
Positron Emission Tomography-Computed Tomography
16%
Human Study
16%
Primary Tumor
16%
Venous Blood
16%
Dosimetry
16%
Biodistribution
16%
Bladder
16%
Clinical Study
16%
Thyroid Gland
16%
Clinical Imaging
16%
Absorbed Dose
16%
Metabolite
16%
Multiple Endocrine Neoplasia Type I
16%
Stomach
16%
Salivary Gland
16%
Triazole
16%
Adverse Event
16%
Pharmacology, Toxicology and Pharmaceutical Science
Fluorine 18
100%
Radioligand
100%
Neuroendocrine Tumor
100%
Primary Tumor
16%
Adverse Event
16%
Biodistribution
16%
Human Study
16%
Syndrome
16%
Clinical Study
16%
Dosimetry
16%
Multiple Endocrine Neoplasia Type 1
16%
Polyethylene Terephthalate
16%
Triazole
16%